<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">63807</article-id><article-id pub-id-type="doi">10.7554/eLife.63807</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>RAL GTPases mediate EGFR-driven intestinal stem cell proliferation and tumourigenesis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-239179"><name><surname>Nászai</surname><given-names>Máté</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-239181"><name><surname>Bellec</surname><given-names>Karen</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-145360"><name><surname>Yu</surname><given-names>Yachuan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-239180"><name><surname>Román-Fernández</surname><given-names>Alvaro</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217015"><name><surname>Sandilands</surname><given-names>Emma</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217016"><name><surname>Johansson</surname><given-names>Joel</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-239182"><name><surname>Campbell</surname><given-names>Andrew D</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42218"><name><surname>Norman</surname><given-names>Jim C</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217017"><name><surname>Sansom</surname><given-names>Owen J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9540-3010</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-85638"><name><surname>Bryant</surname><given-names>David M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2721-5012</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-103669"><name><surname>Cordero</surname><given-names>Julia B</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1701-9480</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>University of Oxford</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution>University of Glasgow</institution>, <addr-line><named-content content-type="city">Glasgow</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">N/A</institution>, <institution>CRUK Beatson Institute</institution>, <addr-line><named-content content-type="city">Glasgow</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff4"><institution content-type="dept">Institute of Cancer Sciences</institution>, <institution>CRUK Beatson Institute</institution>, <addr-line><named-content content-type="city">Glasgow</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff5"><institution content-type="dept">CRUK Beatson Institute</institution>, <institution>CRUK Beatson Institute</institution>, <addr-line><named-content content-type="city">Glasgow</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff6"><institution content-type="dept">Integrin Cell Biologu</institution>, <institution>Beatson Institute</institution>, <addr-line><named-content content-type="city">Glasgow</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1213"><name><surname>Bellen</surname><given-names>Hugo J</given-names></name><role>Reviewing editor</role><aff><institution>Baylor College of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>julia.cordero@glasgow.ac.uk</email> (JC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>07</day><month>06</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e63807</elocation-id><history><date date-type="received"><day>07</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>03</day><month>06</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Nászai et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Nászai et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-63807-v1.pdf"/><abstract><p>RAS-like (RAL) GTPases function in Wnt signalling-dependent intestinal stem cell proliferation and regeneration. Whether RAL proteins work as canonical RAS effectors in the intestine, and the mechanisms of how they contribute to tumourigenesis remain unclear. Here, we show that RAL GTPases are necessary and sufficient to activate EGFR/MAPK signalling in the intestine, via induction of EGFR internalisation. Knocking down <italic>Drosophila</italic> <italic>RalA</italic> from intestinal stem and progenitor cells leads to increased levels of plasma membrane-associated EGFR and decreased MAPK pathway activation. Importantly, in addition to impacting stem cell proliferation during damage-induced intestinal regeneration, this role of RAL GTPases impacts on EGFR-dependent tumorigenic growth in the intestine and in human mammary epithelium. However, the effect of oncogenic RAS in the intestine is independent from RAL function. Altogether, our results reveal previously unrecognised cellular and molecular contexts where RAL GTPases become essential mediators of adult tissue homeostasis and malignant transformation.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>104103/Z/14/Z</award-id><principal-award-recipient><name><surname>Cordero</surname><given-names>Julia B</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>A17196</award-id><principal-award-recipient><name><surname>Yu</surname><given-names>Yachuan</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>A18277,C596/A18076</award-id><principal-award-recipient><name><surname>Norman</surname><given-names>Jim C</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>A21139</award-id><principal-award-recipient><name><surname>Johansson</surname><given-names>Joel</given-names></name><name><surname>Campbell</surname><given-names>Andrew D</given-names></name><name><surname>Sansom</surname><given-names>Owen J</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>A17196</award-id><principal-award-recipient><name><surname>Román-Fernández</surname><given-names>Alvaro</given-names></name><name><surname>Sandilands</surname><given-names>Emma</given-names></name><name><surname>Bryant</surname><given-names>David M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Owen J Sansom, O.J.S. has received funding from Novartis to examine RAL and RAL GEFs in malignancy..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal work has been approved by a University of Glasgow internal ethics committee and performed in accordance with institutional guidelines under personal and project licenses granted by the UK Home Office (PPL PCD3046BA).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data underlying the findings of this study are included in the manuscript and supporting file. Source data files have been provided for all figures containing numeric data. The entire raw data set corresponding to the work in this paper will be publicly available at the time of publication from our institutional repository http://dx.doi.org/10.5525/gla.researchdata.1142. RNA sequencing data has been deposited in GEO (accession GSE162421) and can be accessed through (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE162421). Custom scripts used for quantification are available at  Github: https://github.com/emltwc/TracheaProject/blob/master/Blind_scoring.ijm; https://github.com/emltwc/2018-Cell-Stem-Cell  and https://github.com/emltwc/EGFRProject .</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Mate Naszai</collab><collab>Julia B Cordero</collab></person-group><year iso-8601-date="2021">2021</year><source>RAL GTPases mediate EGFR/MAPK signalling-driven intestinal stem cell proliferation and tumourigenesis upstream of RAS activation.</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE162421">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE162421</ext-link><comment>NCBI Gene Expression Omnibus, GSE162421</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-63807-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>